Play Earnings CallPlay Earnings Call
The Beauty Health Company (SKIN) Q4 2025 Earnings Call March 12, 2026 4:30 PM EDT
Company Participants
Pedro Malha – CEO & President
Michael Monahan – Chief Financial Officer
Conference Call Participants
Norberto Aja – JCIR
K. Gong – JPMorgan Chase & Co, Research Division
Jonna Kim
Alec Legg – Canaccord Genuity Corp., Research Division
Joseph Federico – Stifel, Nicolaus & Company, Incorporated, Research Division
Bruce Jackson – The Benchmark Company, LLC, Research Division
John-Paul Wollam – ROTH Capital Partners, LLC, Research Division
Presentation
Operator
Good day, and welcome to The Beauty Health Company 2025 Fourth Quarter Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Mr. Norberto Aja, Investor Relations. Please go ahead.
Norberto Aja
JCIR
Thank you, operator, and good afternoon, everyone. Thank you for joining The Beauty Health Company’s Fourth Quarter 2025 Conference Call. We released our results earlier this afternoon via an earnings press release, which can be found on our corporate website at beautyhealth.com. Joining me on the call today is BeautyHealth’s Chief Executive Officer, Pedro Malha, along with our Chief Financial Officer, Mike Monahan.
Before we begin, I would like to remind everyone of the company’s safe harbor language. Management may make forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended, including guidance and underlying assumptions. Forward-looking statements are based on current expectations and beliefs and involve risks and uncertainties that could cause actual results to differ materially. Listeners are cautioned not to place undue reliance on forward-looking statements. For further discussion of risks related to our business, please refer to the risk factors contained in the company’s filings with the SEC.
This call will present non-GAAP
